| Radiological classification
A classification system for CT findings was devised to quantify the amount of bony erosion across three subsites (tegmen, posterior fossa (sigmoid notch and medial to the notch) and the otic capsule) ( Figure 1A ,B). The number of subsites for each patient was then recorded ( Figure 2 ). Interval scans on two patients suggest bony erosion occurs early on and does not progress.
During revision surgery, both surgeons noted that the granules were surrounded by soft tissue with no evidence of bony integration. For both obliteration as part of a stage 2 combined approach tympanoplasty and obliteration of an open cavity, the average number of subsites showing bony erosion was 1.38 (Table 1 ). • This was a completely new clinical situation with erosion occurring in asymptomatic patients. Advice was sought from the MHRA leading otologists and radiologists. The MHRA advised that patients should be recalled, examined and CT-scanned to determine the nature of the problem.
| Histology
• SerenoCem Granules TM contain a trace of aluminium but are pre-set, which means that the vast majority of aluminium is released in the setting phase and should not constitute a neurotoxicity risk.
• Lack of progression on CT findings suggests erosion occurs early on and stabilises.
• Regulatory standards of the 1990s were perhaps not sufficiently robust, and nowadays, a more exacting clinical trial would be needed. 
| Comparisons with other studies
Currently, there is one paper in the literature supporting the use of SerenoCem TM granules for mastoid obliteration. The authors reported a postoperative improvement on the Glasgow Benefit Inventory score as well as a reduction in aural care visits; however, the authors also reported that the granules failed to osseointegrate. • undertake a clinical review and CT scan* • consider need for revision surgery with the removal of the granules and obliteration with bone pât e
• repeat CT scan in 2 years if granules remain implanted
Asymptomatic patients:
• undertake clinical review and offer a CT scan* • repeat CT scan in 2 years to assess the rate of reabsorb- There was no associated chronic inflammatory response at 4 weeks. 5 While the laboratory rat femur is a sterile site, in mastoid obliteration, the granules are inserted into a potentially infected and inflamed cavity. This raises the possibility of a biofilm reaction, being the causative factor in the development of bony erosion described in this series. SerenoCem Granules TM contain a trace of aluminium, which may be of concern in those where the granules become adjacent to the dura. GICs in their cement form are generally contraindicated in situations where they will come into contact with neural tissue or nerves.
Excessive aluminium ion exposure has been implicated in a number of diseases; in particular, it exerts direct genotoxicity in neural cells. 9 SerenoCem Granules TM are pre-set, which means the setting phase is already complete at the point of sale and it is also washed out during the manufacturing process. Aluminium ions will therefore not leach out in large amounts compared to known cases of aluminium toxicity, and over time, aluminium release from implanted SerenoCem Granules TM will effectively cease.
The relationship between the aluminium content, ion release and biocompatibility is undoubtedly complex. Brook et al. 2 reported no correlation between the aluminium content, ion release and biocompatibility. Furthermore, the dura is also a strong barrier protecting neural tissue. While relatively little data are available regarding the long-term release of aluminium ions from set glass ionomers in general or SerenoCem Granules TM specifically, this information suggested that after 12 months, the amounts of aluminium that may be released are in the parts-per-million range where they are difficult to detect and would not constitute a risk to human health. In patients with bony erosion on CT scanning, it was felt the benefits of removing the granules were outweighed by the risks of surgery, and therefore, it was suggested that patients should be clinically reviewed annually with a repeat CT scan after 2 years. If at this point there was evidence of progressive erosion, then the patient would be advised to have the granules removed.
| CONCLUSION
Currently, those that have purchased SerenoCem Granules TM have been instructed not to use them, and they have also been withdrawn from the market. The regulatory environment of the 1990s was not sufficiently robust, and with current standards, any new bone graft substitute, even one based on an otherwise biocompatible material, would be subjected to a more exacting clinical trial before use. This is because biocompatibility is specific to a given clinical practice or procedure, rather than an intrinsic property of the actual biomaterial.
We hypothesise that either a foreign body reaction or a biofilm- Most of the cases of limited osteoradionecrosis of the nasopharynx have been treated by endoscopic debridement with a favourable success rate. 3 However, there are no reports of managing chronic non-healing, extensive osteoradionecrosis exposing the carotid artery with necrosis in the parapharyngeal space, which inevitably results in sudden death due to carotid artery bleeding. 2 We speculated that the principal management comprising of radical debridement of the necrotic tissue and free flap reconstruction could be a reasonable treatment option for extensive skull base osteoradionecrosis in patients with nasopharyngeal carcinoma as in other patients with extensive osteoradionecrosis of the head and neck area. 5, 6 In this study, the maxillary swing approach, which has been introduced to perform salvage surgery for recurrent nasopharyngeal cancer, was used to obtain the appropriate surgical field. 7, 8 With this approach, we performed radical debridement of the necrotic soft and bony tissue in the skull base and free muscular flap reconstruction to cover the skull base defect in four patients with extensive osteoradionecrosis with a high possibility of carotid artery rupture and other major fatal complications. All patients were informed of the seriousness of extensive osteoradionecrosis and they agreed to undergo a major surgical intervention.
| MATERIALS AND METHODS

| Ethical considerations
Balloon occlusion test of the carotid artery was performed and it was tolerated in three patients. All patients underwent radical debridement of necrotic tissue in the skull base and free muscular flap reconstruction using the maxillary swing approach. The clinicopathological characteristics with respect to nasopharyngeal carcinoma, osteoradionecrosis and surgical procedures were collected (Table 1) .
